Inuvo, Inc. financials

INUV CIK 0000829323

Source: EDGAR filings · Built 2026-06-19T02:35:00Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -3.41M -1.68M -4.34M -7.37M -7.13M -7.22M
EBITDA -4.46M -3.00M -7.74M -10.05M -4.63M -4.81M
Working Capital -5.08M -2.24M 211.06K 2.78M 12.42M 5.80M
Net Debt 1.19M -1.44M -3.46M -2.45M -9.63M -6.94M
Gross Margin 74.49% 85.64% 85.82% 60.00% 73.38% 81.41%
Operating Margin -7.77% -6.58% -14.06% -16.73% -12.99% -18.03%
Net Margin -5.91% -6.88% -14.06% -17.34% -12.70% -16.36%
Return on Equity (ROE) -50.84% -42.76% -61.18% -60.26% -23.17% -28.88%
Return on Assets (ROA) -20.49% -17.90% -32.09% -36.86% -17.28% -20.76%
Current Ratio 0.64× 0.87× 1.01× 1.20× 2.16× 1.66×
Debt-to-Equity 0.40× 0.08× 0.06× 0.02× 0.03× 0.04×
Effective Tax Rate -0.14% 0.17% 0.00%
Cash Conversion Ratio 0.35× -0.04× 0.25× 0.43× 0.69× 0.77×
Accruals Ratio -0.13× -0.19× -0.24× -0.21× -0.05× -0.05×
SBC % of Revenue 1.33% 1.79% 2.69% 3.11% 3.64% 1.92%
CapEx Coverage -1.10× 0.12× -1.43× -3.10× -2.84× -3.46×
Free Cash Flow Per Share $-0.24 $-0.12 $-0.03 $-0.06 $-0.06 $-0.09

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 86.21M 83.79M
Cost of Goods and Services Sold 12.03M 10.48M 30.24M
Cost of Revenue 22.00M 12.03M 30.24M 15.93M 8.30M
Gross Profit 64.21M 71.76M 63.43M 45.36M 43.90M 36.34M
Selling, General and Administrative Expense 8.62M 7.20M 7.63M
Operating Expenses 70.91M 77.27M 73.83M 58.01M 51.68M 44.39M
Operating Income (Loss) -6.70M -5.51M -10.39M -12.65M -7.77M -8.05M
Income Tax Expense (Benefit) 10.71K 8.03K -17.76K 0 0
Net Income (Loss) Attributable to Parent -5.10M -5.76M -10.39M -13.11M -7.60M -7.30M
Earnings Per Share, Basic $-0.11 $-0.06 $-0.09
Weighted Average Number of Shares Outstanding, Basic 14.48M 14.00M 131.12M 119.83M 117.61M 77.47M
Earnings Per Share, Diluted $-0.04 $-0.08 $-0.11 $-0.06 $-0.09
Weighted Average Number of Shares Outstanding, Diluted 14.48M 14.00M 131.12M 119.83M 117.61M 77.47M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 2.93M 10.48M 7.89M
Assets, Current 9.22M 15.64M 14.74M 16.38M 23.08M 14.53M
Assets 24.87M 32.20M 32.37M 35.56M 44.00M 35.18M
Long-term Debt 0
Liabilities, Current 14.29M 17.89M 14.53M 13.60M 10.66M 8.73M
Stockholders' Equity Attributable to Parent 10.02M 13.47M 16.98M 21.75M 32.81M 25.29M
Common Stock, Shares, Outstanding 14.70M 14.05M 137.98M 120.14M 118.75M 98.04M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -1.79M 229.55K -2.55M -5.57M -5.28M -5.60M
Net Cash Provided by (Used in) Investing Activities -1.60M -1.86M 606.19K -1.67M -4.60M -1.19M
Net Cash Provided by (Used in) Financing Activities 3.77M -353.39K 3.46M -304.43K 12.46M 14.30M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (INUV CIK 0000829323), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

BGLC

BioNexus Gene Lab Corp.

IMUX

Immunic, Inc.

SBSW

Sibanye Stillwater Limited